(Q46533213)
Statements
1 reference
Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trial (English)
1 reference
1 reference
1 reference
Casper Steenholdt
1 reference
Jørn Brynskov
1 reference
Ole Østergaard Thomsen
1 reference
Jan Fallingborg
1 reference
Lisbet Ambrosius Christensen
1 reference
Gitte Pedersen
1 reference
Jens Kjeldsen
1 reference
Bent Ascanius Jacobsen
1 reference
Anne Sophie Oxholm
1 reference
Jakob Kjellberg
1 reference
Klaus Bendtzen
1 reference
22 July 2013
1 reference
1 reference
63
1 reference
6
1 reference
919-927
1 reference